Information platform for Japanese Medicines

Natalizumab (Genetical Recombination) as Active ingredient

TYSABRI for I.V. Infusion 300mg
Medicine name

TYSABRI for I.V. Infusion 300mg

Active ingredient
Natalizumab (Genetical Recombination)
Manufacturer
Biogen Japan
Category
Agents affecting nervous system and sensory organs
Login required
Tags
Please add the drug you wish to request a quote for to your My List.
Have an account?

An account is required to quote and purchase products.

Search Options
Current conditions:
Select categories
Filter clear

This website is available exclusively to healthcare professionals outside of Japan.

Registration and use by the general public are not permitted. Upon member registration, we will verify your credentials related to pharmaceutical transactions.

Are you a healthcare professional outside of Japan?